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Abstract
Introduction Neonatal cardiac surgery is associated with a
systemic inflammatory reaction that might compromise the
reactivity of blood cells against an inflammatory stimulus. Our
prospective study was aimed at testing this hypothesis.
Methods We investigated 17 newborn infants with
transposition of the great arteries undergoing arterial switch
operation. Ex vivo production of the pro-inflammatory cytokine
tumor necrosis factor-α  (TNF-α ), of the regulator of the acute-
phase response IL-6, and of the natural anti-inflammatory
cytokine IL-10 were measured by enzyme-linked immunosorbent
assay in the cell culture supernatant after whole blood
stimulation by the endotoxin lipopolysaccharide before, 5 and
10 days after the operation. Results were analyzed with respect
to postoperative morbidity.
Results The ex vivo production of TNF-α  and IL-6 was
significantly decreased (P < 0.001 and P < 0.002, respectively),
whereas ex vivo production of IL-10 tended to be lower 5 days
after the operation in comparison with preoperative values (P <
0.1). Ex vivo production of all cytokines reached preoperative
values 10 days after cardiac surgery. Preoperative ex vivo
production of IL-6 was inversely correlated with the
postoperative oxygenation index 4 hours and 24 hours after the
operation (P  < 0.02). In contrast, postoperative ex vivo
production of cytokines did not correlate with postoperative
morbidity.
Conclusion Our results show that cardiac surgery in newborn
infants is associated with a transient but significant decrease in
the ex vivo production of the pro-inflammatory cytokines TNF-α
and IL-6 together with a less pronounced decrease in IL-10
production. This might indicate a transient postoperative anti-
inflammatory shift of the cytokine balance in this age group. Our
results suggest that higher preoperative ex vivo production of IL-
6 is associated with a higher risk for postoperative pulmonary
dysfunction.
Introduction
Cardiac surgery is associated with a systemic inflammatory
reaction comprising activation of the complement system,
stimulation of leukocytes, synthesis of cytokines, and
increased interactions between leukocytes and endothelium
[1,2]. In children, contact activation, ischemia/reperfusion
injury and endotoxin released from the gut [3,4] are thought to
be the major inductors of pro-inflammatory cytokines such as
tumor necrosis factor-α  (TNF-α ) and IL-6 in the cardiac sur-
gery setting. In newborn infants, morbidity after cardiac sur-
gery is related to the importance of the intra-operative
production of pro-inflammatory cytokines such as IL-6, as we
have shown previously [5].
NF-κ B is the main transcription factor of many inflammatory
genes, such as that encoding TNF-α  [6]. TNF-α  induces
CPB = cardiopulmonary bypass; CRP = C-reactive protein; IL = interleukin; LPS = lipopolysaccharide; NF-κ B = nuclear factor κ B; TNF-α  = tumor 
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secondary mediators of inflammation such as IL-6, the princi-
pal regulator of the acute-phase response [7]. IL-10 is an anti-
inflammatory cytokine that strongly inhibits the synthesis of
pro-inflammatory cytokines at the transcriptional level by con-
trolling the degradation of the inhibitory protein of NF-κ B, Iκ B,
and thereby the nuclear translocation of NF-κ B [8]. IL-10 has
a central role in the control and termination of systemic inflam-
mation. Although IL-10 is thought to have a protective role in
the early postoperative period, the maintenance of normal
postoperative organ function is likely to depend on an ade-
quate balance between the production of pro-inflammatory
and anti-inflammatory cytokines [9]. It has been suggested
that the overproduction of IL-10 after severe injury might be
associated with a hyporesponsiveness to lipopolysaccharide
(LPS) that carries a higher risk for infections [10].
The ex vivo production of cytokines by whole blood is a widely
accepted method of evaluating the reactivity of immunoreac-
tive and inflammatory cells and their potential for inflammatory
responses [11]. In this study, we tested the hypothesis that




After approval by the Human Ethical Committee of the Aachen
University Hospital as well as written consent from the parents,
17 consecutive newborn infants aged 2 to 13 days (median 8
days) were included in this study. To ensure homogeneity of
the patient group, the inclusion criterion was a simple transpo-
sition of the great arteries, suitable for an arterial switch oper-
ation. All patients received prostaglandin E1 infusion (0.05 µg
kg-1 min-1) before the operation, to maintain patency of the
ductus arteriosus. Preoperative cardiac catheterization for bal-
loon atrioseptostomy and angiography was performed in 13
patients.
Anesthesia, operative management and postoperative 
care
Conventional general anesthesia was conducted with
diazepam, fentanyl sulfate and pancuronium bromide. Periop-
erative antibiotic prophylaxis consisted of cefotiam hydrochlo-
ride (100 mg kg-1 body weight). Dexamethasone (10 mg m-2
body surface area) was administered immediately before
sternotomy.
The standardized neonatal cardiopulmonary bypass (CPB)
protocol included a roller pump, a disposable membrane oxy-
genator and an arterial filter. All patients were operated on
under deep hypothermic CPB, as described previously [5].
Epinephrine (adrenaline), dopamine and sodium nitroprusside
were administered systemically for weaning the patients from
CPB.
Standardized postoperative care was provided. Monitoring
included continuous registration of hemodynamic variables,
diuresis and blood gases. Inotropic support consisted in all
cases of dopamine (5 µg kg-1 min-1) and, if necessary, epine-
phrine (0.05 to 0.2 µg kg-1 min-1) or dobutamine (5 to 7.5 µg
kg-1 min-1) and vasodilatory treatment of sodium nitroprusside
(0.5 to 2 µg kg-1 min-1). Diuretics (furosemide, single dosage
of 0.1 to 1 mg kg-1) and volume substitution, which consisted
of fresh-frozen plasma or human albumin 5%, were adminis-
tered depending on the hemodynamic variables. Postopera-
tive clinical endpoint variables were mean arterial blood
pressure, mean central venous pressure, need for inotropic
support, oxygenation index expressed as the ratio of partial
arterial oxygen tension to fraction of inspired oxygen, minimal
diuresis, maximal serum creatinine and maximal serum gluta-
mate oxaloacetate transaminase values during the first 72
hours after the operation, and duration of inotropic and venti-
latory support.
Blood elements
Leukocyte counts were determined by a Cell-Dyn 3700
(Abbott GmbH & Co. KG, Wiesbaden, Germany).
C-reactive protein
C-reactive protein was determined by laser nephelometry. The
detection limit of this method is 5 mg dl-1.
Ex vivo stimulation
Whole blood culture was performed as described previously
[12]. Blood (1 ml) was withdrawn under sterile conditions from
a peripheral vein and was taken in endotoxin-free tubes (Endo
tube ET; Chromogenix, Haemochrom Diagnostica GmbH,
Essen, Germany) before the operation (median 5 days), as
well as 5 and 10 days after operation. The timing of blood sam-
ples was dictated by the fact that ex vivo production of TNF-α
was reported to be decreased up to the sixth postoperative
day in adults undergoing cardiac surgery [13]. Blood was
mixed in a 1:10 ratio with RPMI 1640 medium containing L-
glutamine and 25 mM Hepes medium (Bio Whittaker Europe,
Verviers, Belgium). Cell cultures were stimulated with LPS
(LPS for cell culture, Escherichia coli, lot 026.B6:L2654;
Sigma, St Louis, MO, USA) at a final concentration of 1 ng ml-
1. In control samples, the LPS volume was replaced with cell
culture medium. Because it has been shown that ex vivo
cytokine production reaches its plateau mainly between 12
and 24 hours after stimulation [14], cell cultures were incu-
bated for 16 hours in a humidified incubator at 37°C in an
atmosphere consisting of a mixture of 5% CO2 and 95% air
(Heraeus HBB 2472b; Heraeus Instruments GmbH, Hanau,
Germany); the supernatant was then separated after centrifu-
gation (2,500 r.p.m. for 3 min) and frozen at -70°C until assay.
Cytokine determination
TNF-α , IL-6 and IL-10 were determined with an immunocyto-
metric assay (Biosource International, Camarillo, CA, USA), inAvailable online http://ccforum.com/content/9/5/R549
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accordance with the manufacturer's recommendations for cell
culture supernatant. It is a solid-phase, enzyme-amplified sen-
sitivity immunoassay performed on microtiter plates based on
the oligoclonal system in which several monoclonal antibodies
directed against distinct epitopes of cytokines are used, per-
mitting a high sensitivity of the assay. The minimal detectable
concentrations are 3 pg ml-1 for TNF-α , 2 pg ml-1 for IL-6, and
1 pg ml-1 for IL-10. The ranges covered by the standard curve
are 0 to 1,700 pg ml-1 for TNF-α , 0 to 2,100 pg ml-1 for IL-6,
and 0 to 1,750 pg ml-1  for IL-10. Samples were diluted
accordingly.
Statistical analysis
Results are expressed as means ± SEM. The data were ana-
lyzed with the nonparametric paired Wilcoxon rank test. The
Spearman rank correlation coefficient was assessed for corre-




Operative data and clinical results are summarized in Table 1.
Seven of the 17 newborn infants showed early postoperative
complications that are summarized in Table 2. Six of the seven
patients with complications had a capillary leak syndrome as
previously described by our group [15]. One patient devel-
oped pneumonia. There was one postoperative death 29 days
after operation in a patient having developed thrombosis of the
right and of the left persistent superior caval veins.
Leukocyte count
There was no statistical difference between the counts of leu-
kocytes, granulocytes and monocytes measured before the
operation, and 5 and 10 days after it (Table 3). Leukocyte
counts were not different in patients with or without
complications.
C-reactive protein
C-reactive protein (CRP) increased in all patients from 7.94 ±
1.27 mg dl-1 before the operation to 15.7 ± 3.7 mg dl-1 5 days
after it. At that time point, CRP values were higher in patients
with complications than in those without (23.8 ± 5.5 versus
10.2 ± 4.3 mg dl-1, P = 0.001). The patient with pneumonia
had a CRP value of 8 mg dl-1 before the operation and 9 mg
dl-1 5 days after the operation, increasing to 50 mg dl-1 12
hours later. CRP values were still elevated in all patients 10
days after the operation (16.6 ± 4.4 mg dl-1), and at that time
there was no difference between patients with and without
complications. The patient with pneumonia had a CRP value
of 8 mg dl-1 at that time.
Ex vivo production of cytokines after LPS stimulation 
before and after operation
At all time points investigated in this study there was a signifi-
cant production of TNF-α , IL-6 and IL-10 after stimulation by
LPS in comparison with the control sample.
Table 1
Clinical and operative data
Variable Value
Age at operation (days) 8 (2–13)
Duration of cardiopulmonary bypass (min) 58 (53–63)
Duration of aortic cross-clamping (min) 62 (54–78)
Mean blood pressure (mmHg)
4 h after operation 65 (48–80)
24 h after operation 53 (47–68)
Diuresis (ml kg-1 h-1)
4 h after operation 7.8 (1.6–17.5)
24 h after operation 7.1 (1–8)
Oxygenation index PaO2/FiO2 (mmHg)
4 h after operation 176.7 (69–283)
24 h after operation 195.5 (63–370)
Aspartate aminotransferase concentration (IU L-1)
4 h after operation 32 (13–66)
24 h after operation 33 (7–162)
Epinephrine dosage (µg kg-1 min-1)
4 h after operation 0.16 (0.02–0.36)
24 h after operation 0.12 (0.02–0.41)
Values are presented as number (n) and range. FiO2, fraction of 
inspired oxygen; PaO2, partial arterial oxygen tension.
Table 2
Postoperative complications
Patient Complications Time after 
operation
Outcome
1 Cardiac arrest after blood 
transfusion
4 h Survived
2 Capillary leak syndromea 24 h Survived
Pneumoniab 5 d
3 Capillary leak syndrome 24 h Survived
4 Capillary leak syndrome 24 h Survived
5 Capillary leak syndrome 24 h Survived
6 Capillary leak syndrome 24 h Survived
7 Capillary leak syndrome 24 h Died
Thrombosis of the right and left 
persistent superior caval 
veins
10 d
aCapillary leak syndrome was diagnosed in accordance with our 
definition [15]. bDiagnosis of pneumonia was made on the basis of 
respiratory insufficiency, a pathological chest X-ray and a secondary 
increase in C-reactive protein.Critical Care    Vol 9 No 5    Schumacher et al.
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Concentrations of TNF-α  and IL-6 in the cell culture superna-
tant were significantly decreased on day 5, in comparison with
preoperative levels (P < 0.001 and P < 0.002, respectively).
Postoperative IL-10 concentrations on day 5 were also
reduced compared with the preoperative value, although not
significantly (P < 0.1). On the 10th day after the operation,
concentrations of TNF-α , IL-6 and IL-10 had returned to their
preoperative levels (Figs 1, 2, 3).
Correlation between ex vivo production of cytokines and 
outcome
In all patients preoperative IL-6 production was inversely cor-
related with the oxygenation index, as measured 4 and 24
hours after the operation (Spearman correlation coefficient: -
0.62; P < 0.02). Figure 4 shows the relationship between pre-
operative ex vivo IL-6 production and the oxygenation index, as
measured 24 hours after the operation. There was no correla-
tion between the ex vivo production of TNF-α  and IL-10 and
postoperative morbidity, respectively. In particular, the only
patient with pneumonia (patient 2 in Table 2) showed ex vivo
cytokine production that was in the same range as for all other
patients.
Table 3
Preoperative and postoperative leukocyte, granulocyte, monocyte and lymphocyte counts
Cell type Cell count
Before operation 5 d after operation 10 d after operation
Leukocytes (Giga l-1) 12.8 ± 1.2 10.1 ± 0.8 11.9 ± 1.3
Granulocytes (%) 53.2 ± 4.2 55.9 ± 3.1 45.2 ± 4.5
Monocytes (%) 3.7 ± 1.5 3 ± 0.6 9.1 ± 1.6
Lymphocytes (%) 37.4 ± 5.9 33.4 ± 4 37.5 ± 3.8
Values are presented as means ± SEM.
Figure 1
Ex vivo production of tumor necrosis factor-α Ex vivo production of tumor necrosis factor-α . Preoperative and post-
operative (po) tumor necrosis factor-α  (TNF-α ) levels in whole blood 
culture supernatant. Values are expressed as means and SEM (error 
bars). TNF-α  production was significantly increased after stimulation 
with lipopolysaccharide (LPS; white), in comparison with the unstimu-
lated control (C; black) at all time points. In comparison with preopera-
tive levels, TNF-α  production after stimulation with LPS significantly 
decreased 5 days after operation (P < 0.001) but again reached preop-
erative levels 10 days after operation.
Figure 2
Ex vivo production of interleukin-6 Ex vivo production of interleukin-6. Preoperative and postoperative (po) 
interleukin (IL)-6 levels in whole blood culture supernatant. Values are 
expressed as means and SEM (error bars). IL-6 production was signifi-
cantly increased after stimulation with lipopolysaccharide (LPS; white), 
in comparison with the unstimulated control (C; black) at all time points. 
In comparison with preoperative levels, IL-6 production after stimulation 
with LPS significantly decreased 5 days after operation (P < 0.002) but 
again reached preoperative levels 10 days after operation.Available online http://ccforum.com/content/9/5/R549
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Discussion
In previous studies we have shown that neonatal cardiac sur-
gery induces a systemic inflammatory reaction with comple-
ment activation, leukocyte stimulation and cytokine synthesis
that is associated with postoperative complications such as
the capillary leak syndrome and myocardial dysfunction
[2,5,15]. In this study we confirm the association between
systemic inflammation and postoperative morbidity. Although
it has been suggested that, in the setting of cardiac surgery,
parenchymatous cells such as cardiomyocytes contribute to
the systemic inflammatory reaction by producing cytokines,
circulating blood cells, in particular leukocytes, are considered
the major source of inflammatory mediators [16,17]. This is
supported by previous studies that report a clear association
between uncontrolled leukocyte activation and early
postoperative morbidity after cardiac surgery in newborn
infants and in children [5,15].
The systemic inflammatory reaction induced by cardiac sur-
gery is normally controlled by a natural anti-inflammatory
response. Indeed, levels of IL-10 are already increased at the
end of the operation and remain substantially elevated for at
least 48 hours after the operation [18].
Although the anti-inflammatory response to cardiac surgery is
thought to be beneficial with regard to early postoperative
organ protection [17], it remains unclear whether it could
impair leukocyte reactivity and thereby decrease resistance
against infections.
In this study, the reactivity of circulating cells after neonatal
cardiac surgery was evaluated by the ex vivo production of
pro-inflammatory and anti-inflammatory cytokines after a
standardized inflammatory stimulus in a homogenous patient
group.
A previous study in older children who had undergone cardiac
surgery for various cardiac defects showed decreased ex vivo
cytokine production on the morning of the first postoperative
day. However, later time points, to document the normalization
of cytokine production, were not investigated [19]. One main
result of our study is that neonatal cardiac surgery is associ-
ated with a transiently decreased ex vivo production of the
pro-inflammatory cytokines TNF-α  and IL-6, and that this is not
related to a decrease in leukocyte count. This indicates
impaired reactivity of inflammatory cells. In adults this phenom-
enon has been reported after cardiac surgery [13], severe
injury and sepsis, and defined as hyporesponsiveness to LPS
[20,21]. In adults who have undergone cardiac surgery, ex
vivo TNF-α  production and TNF-α  mRNA in whole blood were
still lower at the end of the study period, which was 6 days
after surgery [13]. We also investigated the ex vivo production
of cytokines at a later time point and show a return of TNF-α
production to preoperative values 10 days after cardiac sur-
gery. The reason for the transient impairment of leukocyte
reactivity in our series could be ascribed to the exhaustion of
circulating inflammatory cells due to the massive inflammatory
stress due to cardiac surgery and also to the perioperative
treatment applied. With this regard, drugs administered
Figure 3
Ex vivo production of interleukin-10 Ex vivo production of interleukin-10. Preoperative and postoperative 
(po) IL-10 levels in whole blood culture supernatant. Values are 
expressed as means and SEM (error bars). IL-10 production was signif-
icantly increased after stimulation with lipopolysaccharide (LPS; white), 
in comparison with the control (C; black) at all time points. In compari-
son with preoperative levels, IL-10 production after stimulation with 
LPS tended to decrease 5 days after operation but again reached pre-
operative levels 10 days after operation.
Figure 4
Relationship between preoperative production of interleukin-6 (IL-6)  and postoperative pulmonary dysfunction Relationship between preoperative production of interleukin-6 (IL-6) 
and postoperative pulmonary dysfunction. Plot showing the correlation 
between preoperative IL-6 production after stimulation with lipopolysac-
charide (LPS) and the oxygenation index 24 hours after operation (n = 
14). Spearman correlation coefficient -0.62; P < 0.02.Critical Care    Vol 9 No 5    Schumacher et al.
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before, during and after the operation could have influenced
hyporesponsiveness to LPS. Indeed, prostaglandin E1 has
been shown to reduce the ex vivo production of TNF-α  and IL-
1β  by adult monocytes [22]. However, in our patients who
were all treated with prostaglandin-E1 infusion before the oper-
ation, preoperative levels of cytokines measured in the super-
natant of the whole blood culture were similar to those after
stimulation of cord blood in healthy newborn infants [12]. This
suggests a minor effect of prostaglandin-E1 on the ex vivo pro-
duction of cytokines in our study. In adults, anesthesia and
heparin were shown not to influence the ex vivo production of
TNF-α  [13].
The course of ex vivo IL-10 production after cardiac surgery
has so far not been followed for more than 6 hours after CPB.
In a previous study, IL-10 production reached its lowest point
2 hours after cardiac surgery in adult patients and returned to
preoperative values 6 hours later [10]. Our results, in contrast,
show that in newborn infants the ex vivo production of IL-10
was decreased 5 days after the operation, even though not
significantly in comparison with preoperative values. This
reduction could be the result of negative feedback by IL-10,
which inhibits not only pro-inflammatory cytokines but also its
own production.
The exact mechanisms leading to hyporesponsiveness to LPS
in newborn infants reported here are not yet clear. However,
the anti-inflammatory cytokines IL-10 and tissue growth factor-
β  are thought to be important in its regulation [23]. In a clinical
study, adult patients with sepsis or severe trauma showed a
reduced expression of the active form of NF-κ B [24]. In those
who did not survive, the IL-10 plasma levels were inversely cor-
related to the ratio between the active and inhibitory forms of
NF-κ B, supporting the view that IL-10 might participate in the
induction of LPS hyporesponsiveness by inhibiting cytokine
synthesis at or upstream of the transcriptional level.
Newborn infants who have undergone cardiac surgery have
been reported to show a higher natural production of IL-10
than older children [25]. For the reasons cited above, this nat-
ural anti-inflammatory cytokine imbalance could well have con-
tributed to the hyporesponsiveness to LPS observed in our
series. Furthermore, as reported by others in older children
operated on with CPB [19], perioperative treatment with dex-
amethasone could also have contributed to hyporesponsive-
ness to LPS by inhibiting the activation of NF-κ B and thereby
the production of pro-inflammatory cytokines [26], as well as
by stimulating the production of IL-10 [27,28].
Although a clear association has been demonstrated between
hyporesponsiveness to LPS and poor clinical outcome in sep-
sis [24], we were not able to confirm such an association in
our series. One reason for this might be that, in the small group
of patients investigated, the overall rate of complications
related to inflammation or infection was low.
In contrast, we observed a clear association between the pre-
operative ex vivo production of IL-6 and postoperative respira-
tory morbidity. This suggests that a higher preoperative
potential for ex vivo production of IL-6 is a risk factor for inflam-
mation-related postoperative complications in newborn
infants.
Conclusion
Our results show for the first time that cardiac surgery in new-
born infants is associated with a transient but significant
decrease in the ex vivo production of the pro-inflammatory
cytokines TNF-α  and IL-6 together with a less pronounced
decrease in IL-10 production. This suggests a postoperative
anti-inflammatory shift of the cytokine balance in this age
group 5 days after cardiac surgery. A higher preoperative ex
vivo production of IL-6 might indicate a higher risk for postop-
erative pulmonary dysfunction. Further studies will address the
question of whether preoperative ex vivo production of IL-6
would be a suitable predictor of postoperative complications
in newborn infants with congenital cardiac defects.
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